{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:51:41Z","timestamp":1758959501692},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00638","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:09:17Z","timestamp":1485382157000},"page":"266-271","source":"Crossref","is-referenced-by-count":7,"title":["Effects of Combined Treatment with Branched-Chain Amino Acids, Citric Acid, L-Carnitine, Coenzyme Q10, Zinc, and Various Vitamins in Tumor-Bearing Mice"],"prefix":"10.1248","volume":"40","author":[{"given":"Hiroko","family":"Awa","sequence":"first","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Futamura","sequence":"additional","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Higashiguchi","sequence":"additional","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoharu","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyo","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Surgery and Palliative Medicine, School of Medicine, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Chihara","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Fujita Memorial Nanakuri Institute, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Fujita Memorial Nanakuri Institute, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) August DA. Nutritional Care of Cancer patients. <i>Surgery. Basic Science and Clinical Evidence<\/i>. (Norton JA, Bollinger PR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, Thompson RW eds.) Springer-Verlag, New York, pp. 1841\u20131862 (2000)."},{"key":"2","unstructured":"2) Tisdale MJ. Pathogenesis of cancer cachexia. <i>J. Support. Oncol.<\/i>, <b>1<\/b>, 159\u2013168 (2003)."},{"key":"3","unstructured":"3) Higashiguchi T, Ito A, Iida T, Murai M. Fluid therapy in terminal cancer patients. <i>Japan. Med. Assoc. J.<\/i>, <b>132<\/b>, 61\u201364 (2004)."},{"key":"4","unstructured":"4) Higashiguchi T. Nutritional management for the elderly and terminally ill patients. <i>Byouin<\/i>, <b>65<\/b>, 146\u2013151 (2006)."},{"key":"5","unstructured":"5) Higashiguchi T. The roles of a nutrition support team. <i>Nippon Geka Gakkai Zasshi<\/i>, <b>105<\/b>, 206\u2013212 (2004)."},{"key":"6","unstructured":"6) Higashiguchi T, Futamura A, Ito A. Effect of a complementary nutrition diet for improving clinical condition and function in terminal cancer patients: A controlled clinical trial. <i>Jpn. J. Surg. Metab. Nutr.<\/i>, <b>44<\/b>, 157\u2013169 (2010)."},{"key":"7","unstructured":"7) Higashiguchi T, Futamura A, Ito A, Yaga S, Ohkawa T, Ohkawa H. A clinical study of the immediate and delayed effects of new dietary supplements on exercise-related fatigue and the inhibition of delayed-onset muscle soreness. <i>Ann. Public Health Res.<\/i>, <b>1<\/b>, 1010 (2014)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner M, Zimmermann R, Vesely P, Haemmerle G, Zechner R, Hoefler G. Adipose triglyceride lipase contributes to cancer-associated cachexia. <i>Science<\/i>, <b>333<\/b>, 233\u2013238 (2011).","DOI":"10.1126\/science.1198973"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Peinado H, Ale\u010dkovi\u0107 M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garc\u00eda-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. <i>Nat. Med.<\/i>, <b>18<\/b>, 883\u2013891 (2012).","DOI":"10.1038\/nm.2753"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fujitsuka N, Uezono Y. Rikkunshito, a ghrelin potentiator, ameliorates anorexia\u2013cachexia syndrome. <i>Front Pharmacol.<\/i>, <b>5<\/b>, 271 (2014).","DOI":"10.3389\/fphar.2014.00271"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nishitani S, Horie M, Ishizaki S, Yano H. Branched-chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin. <i>PLoS ONE<\/i>, <b>8<\/b>, e82346 (2013).","DOI":"10.1371\/journal.pone.0082346"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. <i>Am. J. Physiol. Endocrinol. Metab.<\/i>, <b>307<\/b>, E469\u2013E484 (2014).","DOI":"10.1152\/ajpendo.00204.2014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, Wolchok J, Bhardwaj N, Merad M, Saenger Y. Requirement for innate immunity and CD90<sup>+<\/sup> NK1.1<sup>\u2212<\/sup> lymphocytes to treat established melanoma with chemo-immunotherapy. <i>Cancer Immunol. Res.<\/i>, <b>3<\/b>, 296\u2013304 (2015).","DOI":"10.1158\/2326-6066.CIR-14-0120"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kayaga J, Souberbielle BE, Sheikh N, Morrow WJW, Scott-Taylor T, Vile R, Chong H, Dalgleish AG. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine. <i>Gene Ther.<\/i>, <b>6<\/b>, 1475\u20131481 (1999).","DOI":"10.1038\/sj.gt.3300961"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bruns H, Bessell C, Varela JC, Haupt C, Fang J, Pasemann S, Mackensen A, Oelke M, Schneck JP, Sch\u00fctz C. CD47 enhances <i>in vivo<\/i> functionality of artificial antigen-presenting cells. <i>Clin. Cancer Res.<\/i>, <b>21<\/b>, 2075\u20132083 (2015).","DOI":"10.1158\/1078-0432.CCR-14-2696"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Cantor JM, Rose DM, Slepak M, Ginsberg MH. Fine-tuning tumor immunity with integrin trans-regulation. <i>Cancer Immunol. Res.<\/i>, <b>3<\/b>, 661\u2013667 (2015).","DOI":"10.1158\/2326-6066.CIR-13-0226"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, Gorkiewicz G, Tamilarasan KP, Kumari P, Trauner M, Zimmermann R, Vesely P, Haemmerle G, Zechner R, Hoefler G. Adipose triglyceride lipase contributes to cancer-associated cachexia. <i>Science<\/i>, <b>333<\/b>, 233\u2013238 (2011).","DOI":"10.1126\/science.1198973"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Li H, Gupta S, Du WW, Yang BB. MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response. <i>Oncoscience<\/i>, <b>1<\/b>, 531\u2013539 (2014).","DOI":"10.18632\/oncoscience.69"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Huang H, Liu N, Guo H, Liao S, Li X, Yang C, Liu S, Song W, Liu C, Guan L, Li B, Xu L, Zhang C, Wang X, Dou QP, Liu J. L-Carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth <i>in vivo<\/i> and <i>in vitro.<\/i> <i>PLoS ONE<\/i>, <b>7<\/b>, e49062 (2012).","DOI":"10.1371\/journal.pone.0049062"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Icard P, Poulain L, Lincet H. Understanding the central role of citrate in the metabolism of cancer cells. <i>Biochim. Biophys. Acta<\/i>, <b>1825<\/b>, 111\u2013116 (2012).","DOI":"10.1016\/j.bbcan.2011.10.007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Fouad AA, Al-Mulhim AS, Jresat I. Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats. <i>Environ. Toxicol. Pharmacol.<\/i>, <b>35<\/b>, 100\u2013108 (2013).","DOI":"10.1016\/j.etap.2012.11.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Prasad AS. Zinc: An antioxidant and anti-inflammatory agent: Role of zinc in degenerative disorders of aging. <i>J. Trace Elem. Med. Biol.<\/i>, <b>28<\/b>, 364\u2013371 (2014).","DOI":"10.1016\/j.jtemb.2014.07.019"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Wong CP, Rinaldi NA, Ho E. Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation. <i>Mol. Mutr. Food Res.<\/i>, <b>59<\/b>, 991\u2013999 (2015).","DOI":"10.1002\/mnfr.201400761"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Liu KA, Lashinger LM, Rasmussen AJ, Hursting SD. Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice. <i>Cancer Metab.<\/i>, <b>2<\/b>, 6 (2014).","DOI":"10.1186\/2049-3002-2-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Diaz-Meco MT. Targeting leucine addiction and autophagy in melanoma. <i>Pigment Cell Melanoma Res.<\/i>, <b>24<\/b>, 588\u2013589 (2011).","DOI":"10.1111\/j.1755-148X.2011.00877.x"},{"key":"26","unstructured":"26) WHO\/FAO\/UNU. Protein and amino acid requirements in human nutrition. <i>WHO Technical Report Series 935<\/i>, WHO, Geneva. (2007)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal JM, van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. <i>J. Appl. Toxicol.<\/i>, <b>21<\/b>, 15\u201323 (2001).","DOI":"10.1002\/jat.727"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Eley HL, Russell ST, Tisdale MJ. Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. <i>Biochem. J.<\/i>, <b>407<\/b>, 113\u2013120 (2007).","DOI":"10.1042\/BJ20070651"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/3\/40_b16-00638\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:13:55Z","timestamp":1568765635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/3\/40_b16-00638\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00638","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}